COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN

DSpace/Manakin Repository

COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
 
Vreman, R.; van Nuland, M.; ten Ham, R.M.; de Vries-Schultink, A.H.; Rosing, H.; Schellens, J.H.; Beijnen, J.H.; Hovels, A.M.
(2018) Value in Health, volume 21, issue Supplement 3, pp. S46 - S46
(Article)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
 
Keywords: adjuvant, endogenous compound, endoxifen, estrogen receptor alpha, tamoxifen, adult, breast cancer, cancer adjuvant therapy, cancer patient, cancer recurrence, cancer survival, clinician, conference abstract, controlled study, cost effectiveness analysis, death, diagnostic test accuracy study, disease free survival, drug efficacy, drug monitoring, drug therapy, female, human, human tissue, major clinical study, Netherlands, probability, quality adjusted life year, sensitivity analysis, Taverne
DOI: https://doi.org/10.1016/j.jval.2018.09.273
ISSN: 1098-3015
Publisher: Elsevier Ltd
(Peer reviewed)
 
 
See more statistics about this item